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Bone Metastasis. Eds. L. WEISS & H. A.
GILBERT (1981). Boston: G. K. Hall.
512 pp. £34.50 net.
This large, multi-author book is based on a
workshop on bone metastasis held in the USA
in late 1979, and is aimed primarily at a
clinical audience. An initial section provides a
background of anatomical, histological and
biochemical studies; a second section deals
with aspects of diagnosis; a therapy section
covers the three major modalities, with
emphasis on radiotherapy. Inevitably, the
book reflects mainly the North American
experience.
The editors consider that an advantage of
their single-site volumes on metastasis, of
which this is the fourth, is that greater
depth of examination of a specific problem is
possible. The editorial question must then
arise of how much to include of the back-
ground "width" from the original workshop.
A detailed paper on cell shedding from
tumours uses the word "bone" once, in the
Conclusion. Papers on mechanisms of bone
metastasis and subsequent development
overlap in a number of respects, notably in
the discussion of osteoclast activating factor
and the role of prostaglandins. Diagnosis,
encompassing pathology, radiology, scinti-
graphy and CT scanning, forms a compact,
coherent section and is well illustrated. The
therapy/management section is less easy to
read. A long article on pharmacokinetics and
distribution of cytotoxic drugs has little to
say on bone uptake, because little is known.
Two well documented papers on clini-
cal chemotherapy do emphasise the bone
dimension. A paper on pain relief, a major
consideration in patients with bone metas-
tases, presents an extensi-ve, annotated list
of analgesics but again, directly-relevant
information is as yet limited. Seven succes-
sive articles discuss palliative radiotherapy,
touching on the relative efficacy and econo-
mics of low- and high-dose per fraction
regimes and the role of half-body irradiation.
A twelve-page paper on rehabilitation of the
cancer patient contains six sentences on
specific problems of patients with bone
metastases and sequelae.
The book will provide readers with a
starting point into the literature on most
aspects of bone metastases, but it could have
been a much leaner production.
J. V. MOORE R. D. HUNTER
Prostatic Cancer. R. J. ABLIN (1982). New
York: Marcel Dekker Inc. 321 pp.
The appearance of this book is timely since
it considers a disease whose prevalence is
known to be increasing to the extent that it is
now the second or third commonest cause of
cancer-related death in the Western World.
Set against this, the past decade has seen
much published work on all aspects of the
disease, a number of conferences at inter-
national level and the formation in various
countries of working groups of clinicians and
laboratory workers dedicated to its surveil-
lance and management. A wealth of new
material has therefore warranted the compi-
lation of a book which is unique in bringing
so much of this together in one volume.
Essentially therefore the book consists of a
series of chapters on well selected topics to
give a more or less complete coverage of
progress in the elucidation of all of the main
aspects of the disease, its assessment and its
management. Each chapter provides a use-
ful overview on the particular topic and
perhaps this is the single biggest attribute
of the book.
Like every book there are the strengths
and the weaknesses and there are particu-
larly good chapters dealing with the origin
and evolution of prostatic cancer, the animal
models available and the immunological
aspects of the tumour with the possibilities
therein for the use of immunotherapy in
treatment. Perhaps due to rapid advance in
the technique of rectalultrasonography of
the gland the chapter devoted to this is
somewhat restricted and the ultrasonograms
are not of the quality that would convince
anyone who is not already familiar with what
can be achieved now by this modality of
investigation. Various chapters dwell on the
difficulty in the diagnosis, evaluation and
staging of the disease and draw the lessonBOOK REVIEWS 831
that this has been a major constraint on
progress in the assessment of the various
forms of treatment. The difficulty ofdeciding
what is and what is not a cancer remains and
the chapter on the clinico-histopathologic
evaluation of prostatic cancer competently
tackles this question. Even here however one
wonders whether some of the examples
described as cancer are not in fact variants of
normal, functional prostatic acini.
These are, however, small criticisms in a
book which provides admirable coverage of
the subject in the manner of a series of over-
views. It will appeal to specialists in urology
and to clinical co-workers who participate
in the management of this disease. It will
also have an appeal for laboratory and
research workers who are involved in its
study. The book is well produced and well
edited, each chapter having its own biblio-
graphy, and there is an enjoyable summari-
zation of the book contents by the editor as
a concluding chapter.
N. J. BLACKLOCK
The Practice of Cancer Surgery. Eds.
A. E. ALFONSO & B. GARDNER (1982).
Hemel Hempstead: Prentice Hall. 477 pp.
£31.90 net.
This book provides brief accounts of cell
kinetics, cancer chemotherapy, radiotherapy,
tumour immunotherapy and pathology. The
surgery of cancer at various primary sites is
then described. The professed aim is to
provide "a fundamental practical guideline
outlining current basic principles in the
surgical management of cancer patients".
The result is disappointing. Different
contributors have placed quite different
emphasis on principles of diagnosis, treat-
ment and results. The suggested staging
methods for breast cancer are too detailed to
be of practical value, eleven pages are
devoted to the operations for carcinoma of
the stomach, but urinary diversion, following
total cystectomy, is dismissed in two lines
and the possible postoperative problems are
not mentioned. The legend for Fig. 18.1
needs correction. The book cannot be
recommended to undergraduates or post-
graduates reading for the FRCS diploma
and practising surgeons will find little to
enlighten them.
L. TURNER
Hormone Therapy. Ed. B. J. A. FURR
(1982). London: W. B. Saunders Company
Ltd. 312 pp. £10.75 net.
This issue of Clinics in Oncology "aims to
review the existing approaches to therapy of
hormone responsive tumours and to high-
light current problems and controversy". In
a thoughful opening chapter, Stoll considers
the mechanisms of hormonally-induced re-
gression, the heterogeneity of hormone-
dependent tumours and the stringent
criteria by which we judge response. In the
latter context, it is important to be aware
that the survival times of patients whose
disease shows no change on treatment is
similar to partial responders. Stoll also
emphasis that hormone-dependent tumours
are often slow to respond and these are then
often slow to progress and that we should be
aware of too hurried evaluation of disease
status. Jordan gives an excellent concise
review, including the limitations of animal
models of hormone-dependent cancer.
The prostate is represented by a review of
the mechanism of action and clinical use of
the anti-androgens cyproterone acetate and
flutamide. These compounds are discussed
again in an overview of hormone therapy of
prostate carcinoma.
The breast is covered by a concise review
of anti-oestrogens by Manni and Pearson and
an excellent extensive review of aromatase
inhibitors by Santen and Brodie. The book
is worth acquiring for the latter article
alone. De Sombre covers steroid receptors
and Forbes was given the unenviable task
ofreviewing the whole ofendocrine therapy in
breast cancer. Because of the repetition of
data discussed in other chapters, and the
necessarily superficial treatment, an in-
depthreview oftheuse ofprogesterones would
perhaps have been more appropriate. There
are other chapters on endometrial carcinoma,
lymphoma and leukaemia, thyroid carcinoma
and pituitary adenomas. The final chapter is
a review by the Editor, B. J. A. Furr, on
future prospects for hormone therapy, partic-
ularly the use of LHRH analogues and anti-
oestrogens with less agonist activity. He
emphasises the need for us to know more
about growth factors and the importance of
the extracellular matrix, two very important
areas for research in the next decade.
This book has some excellent chapters and
can be recommended to those interested in